Patent details

EP2542079 Title: TREATMENT OF RHEUMATOID ARTHRITIS WITH A COMBINATION OF LAQUINIMOD AND METHOTREXATE

Basic Information

Publication number:
EP2542079
PCT Application Number:
PCT/US/2011/026885
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117513002
PCT Publication Number:
WO/2011/109531
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF RHEUMATOID ARTHRITIS WITH A COMBINATION OF LAQUINIMOD AND METHOTREXATE
French Title of Invention:
TRAITEMENT DE LA POLYARTHRITE RHUMATOÏDE AU MOYEN D'UNE COMBINAISON DE LAQUINIMOD ET DE MÉTHOTREXATE
German Title of Invention:
BEHANDLUNG RHEUMATOIDER ARTHRITIS MIT EINER KOMBINATION AUS LAQUINIMOD UND METHOTREXAT
SPC Number:

Dates

Filing date:
02/03/2011
Grant date:
21/05/2014
EP Publication Date:
21/05/2014
PCT Publication Date:
09/09/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/01/2013
EP B1 Publication Date:
21/05/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/03/2015
Expiration date:
02/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/03/2011
 
 

Name:
Teva Pharmaceutical Industries Ltd.
Address:
5 Basel Street P.O. Box 3190, 49131 Petach-Tikva, Israel (IL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
16/07/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KAYE Joel
Address:
Israel (IL)

2

Name:
TARCIC Nora
Address:
Israel (IL)

3

Name:
BLAUGRUND Eran
Address:
Israel (IL)

Priority

Priority Number:
339375 P
Priority Date:
10/12/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4704;
Filing date Document type Number of pages